Understanding Decentralized Clinical Trials (DCTs) and Virtual Study Visits

Introduces DCT models and components, and provides best practices for virtual study visits.

Questions? Contact Us
Scroll Down Arrow


About this Webinar

Decentralized clinical trials (DCTs) use processes and technologies that differ from traditional clinical trials. DCTs use telemedicine and mobile and local healthcare providers, conduct visits virtually, obtain consent remotely, and vary from being completely site-less to incorporating virtual elements.

This webinar introduces DCTs (also called virtual trials) and explores the evolution from traditional trials to decentralized models. It discusses the potential benefits to sites and subjects, and barriers to adaptation. It explains terminology and components of DCTs and reviews regulatory considerations when conducting them. It concludes with a discussion of the types of research protocols that may best include virtual aspects and “web-side” practices when conducting virtual study visits.

Webinar Demo:

Language Availability: English

Suggested Audiences: Clinical Investigators, Clinical Research Coordinators, Graduate Students, IRB Administrators, IRB Chairs, IRB Members, Students

Organizational Subscription Price: $300 per year/per site or included as part of the $1,000 annual subscription to our All Access Webinar Package
Independent Learner Price: $49 per person

Demo Instructions


Webinar Content

Understanding Decentralized Clinical Trials (DCTs) and Virtual Study Visits

Presented by: Amanda Rangel, MS, CCRC - VirTrial, a Signant Health Company

Learning Objectives:

  • Identify differences between traditional trials and decentralized clinical trials.
  • Review brief history of development of DCTs.
  • Learn about the terminology, regulations, and best practices of DCTs.
  • Learn appropriate preparation for, interactions during, and overall conduct for virtual visits.

Recommended Use: Required
ID (Language): 20398 (English)